74
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis

, , &
Pages 339-348 | Published online: 08 Apr 2014

References

  • Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD)Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Revised 2011BarcelonaGlobal Initiative for Chronic Obstructive Pulmonary Disease2011 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdfAccessed February 26, 2014
  • nhlbi.nih.gov [homepage on the Internet]2012NHLBI mortality and morbidity chartbookNational Heart, Lung, and Blood Institute2012 [updated May 2013]. Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.htmAccessed February 26, 2014
  • HanMKUpdate in chronic obstructive pulmonary disease in 2010Am J Respir Crit Care Med2011183101311131521596833
  • GuarascioAJRaySMFinchCKSelfTHThe clinical and economic burden of chronic obstructive pulmonary disease in the USAClinicoecon Outcomes Res2013523524523818799
  • DalalAAShahMD’SouzaAORanePCosts of COPD exacerbations in the emergency department and inpatient settingRespir Med2011105345446020869226
  • OostenbrinkJBRutten-van MölkenMPResource use and risk factors in high-cost exacerbations of COPDRespir Med200498988389115338802
  • SullivanSDRamseySDLeeTAThe economic burden of COPDChest200011725S9S10673466
  • StuartBDoshiJABriesacherBWrobelMVBaysacFImpact of prescription coverage on hospital and physician costs: a case study of Medicare beneficiaries with chronic obstructive pulmonary diseaseClin Ther200426101688169915598486
  • DonaldsonGCMüllerovaHLocantoreNFactors associated with change in exacerbation frequency in COPDRespir Res2013147923899210
  • PatelARHurstJRExtrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the artExpert Rev Respir Med20115564766221955235
  • BurgePSPrevention of exacerbations: how are we doing and can we do better?Proc Am Thorac Soc20063325726116636095
  • OzyilmazEKokturkNTeksutGTatliciogluTUnsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary diseaseInt J Clin Pract201367769169723758448
  • Rascon-AguilarIEPamerMWludykaPRole of gastroesophageal reflux symptoms in exacerbations of COPDChest200613041096110117035443
  • TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax2008631195195518535116
  • SakaeTMPizzichiniMMTeixeiraPJda SilvaRMTrevisolDJPizzichiniEExacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysisJ Bras Pneumol201339325927123857694
  • KimJLeeJHKimYAssociation between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort studyBMC Pulm Med20131315123927016
  • cdc.gov [homepage on the Internet]Chronic obstructive pulmonary disease among adults – United States2011Centers for Disease Control and Prevention2012 [updated November 23, 2012; cited July 6, 2013]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htmAccessed February 26, 2014
  • Centers for Disease Control and Prevention (CDC)Chronic obstructive pulmonary disease among adults – United States, 2011MMWR Morb Mortal Wkly Rep2012614693894323169314
  • MenzinJBoulangerLMartonJThe economic burden of chronic obstructive pulmonary disease (COPD) in a US Medicare populationRespir Med200810291248125618620852
  • cms.gov [homepage on the Internet]Medicare Current Beneficiary SurveyCenters for Medicare and Medicaid Services2013 [updated July 18, 2013; cited August 6, 2013]. Available from: http://www.cms.gov/Research-Statistics-Data-and-Systems/Research/MCBS/index.html?redirect=/MCBSAccessed February 26, 2014
  • DalalAAShahMvaAOChaudhariSCraterGClinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression populationInt J Chron Obstruct Pulmon Dis20127111922315518
  • HalpernRBakerCLSuJOutcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary diseasePatient Prefer Adherence2011537538821845037
  • MakeBDutroMPPaulose-RamRMartonJPMapelDWUndertreatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
  • GershonASWangCGuanJVasilevska-RistovskaJCicuttoLToTIdentifying individuals with physician diagnosed COPD in health administrative databasesCOPD20096538839419863368
  • bls.gov [homepage on the Internet]Consumer price indexBureau of Labor Statistics, Department of Labor2001 [updated October 16, 2001; cited August 10, 2013]. Available from: http://www.bls.gov/cpi/cpiovrvw.htmAccessed February 26, 2014
  • GersonLBMcLaughlinTBaluSJacksonJLunacsekOVariation of health-care resource utilization according to GERD-associated complicationsDis Esophagus201225869470122292744
  • AndersenRMRevisiting the behavioral model and access to medical care: does it matter?J Health Soc Behav19953611107738325
  • HalvorsenRPPalmquistRThe interpretation of dummy variables in semilogarithmic equationsAm Econ Rev1980703474475
  • BlinderASWage discrimination: Reduced form and structural estimatesJ Hum Resour197384436455
  • OaxacaRMale-female wage differentials in urban labor marketsInt Econ Rev1973143693709
  • CottonJOn the decomposition of wage differentialsRev Econ Stat1988702236243
  • NewumarkDEmployers’ discriminatory behavior and the estimation of wage discriminationJ Hum Resour1988233279295
  • OaxacaRLRansomMRIdentification in detailed wage decompositionsRev Econ Stat1999811154157
  • ReimersCWLabor market discrimination against hispanic and black menRev Econ Stat1983654570579
  • MoreheadRSGastro-oesophageal reflux disease and non-asthma lung diseaseEur Respir Rev20091811423324320956148
  • BriggsDDDohertyDELong-term pharmacologic management of patients with chronic obstructive pulmonary diseaseClin Cornerstone2004Suppl 2S17S2815500180
  • TurbyvilleJCApplying principles of physics to the airway to help explain the relationship between asthma and gastroesophageal refluxMed Hypotheses20107461075108020080360
  • O’DonnellDEHyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary diseaseProc Am Thorac Soc20063218018416565429
  • El-SeragHHillCJonesRSystematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research DatabaseAliment Pharmacol Ther200929547048019035977
  • AjmeraMWilkinsTLFindleyPASambamoorthiUMultimorbidity, mental illness, and quality of care: Preventable hospitalizations among Medicare beneficiariesInt J Family Med2012201282329423320168
  • MarengoniAAnglemanSMelisRAging with multimorbidity: a systematic review of the literatureAgeing Res Rev201110443043921402176
  • Centers for Medicare and Medicaid ServicesCMS finalizes physician payment rates for 2014 [press release]Baltimore, MDCenters for Medicare and Medicaid Services2013 [November 27]. Available from: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-Releases/2013-Press-Releases-Items/2013-11-27-2.htmlAccessed December 05, 2013
  • CookeCRJooMJAndersonSMThe validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary diseaseBMC Health Serv Res2011113721324188